Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial-Reference-Cited by-同舟云学术

Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial

Published:2016-05-18 Issue:5 Volume:11 Page:e0155702
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Joachim Agricola^ORCID,Bauer Asli,Joseph Sarah,Geldmacher Christof,Munseri Patricia J.,Aboud Said,Missanga Marco,Mann Philipp,Wahren Britta,Ferrari Guido,Polonis Victoria R.,Robb Merlin L.,Weber Jonathan,Tatoud Roger,Maboko Leonard,Hoelscher Michael,Lyamuya Eligius F.,Biberfeld Gunnel,Sandström Eric,Kroidl Arne,Bakari Muhammad,Nilsson Charlotta,McCormack Sheena

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Prospects for a globally effective HIV-1 vaccine;JL Excler;Vaccine,2015

2. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection;NM Flynn;J Infect Dis,2005

3. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand;P Pitisuttithum;J Infect Dis,2006

4. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial;SP Buchbinder;Lancet,2008

5. Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study;GE Gray;Lancet Infect Dis,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis of Pregnancy Events in Biomedical HIV Prevention Trials in Sub-Saharan Africa: Implications for Gender Transformative Trials;AIDS and Behavior;2024-08-17

2. Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases;Journal of Molecular Biology;2023-08

3. Systematic comparison of HIV-1 Envelope-specific IgG responses induced by different vaccination regimens: Can we steer IgG recognition towards regions of viral vulnerability?;Frontiers in Immunology;2023-01-09

4. The Prevalence, Incidence, and Risk Factors for HIV Among Female Sex Workers—A Cohort Being Prepared for a Phase IIb HIV Vaccine Trial in Dar es Salaam, Tanzania;JAIDS Journal of Acquired Immune Deficiency Syndromes;2022-09-20

5. The Results of Clinical Trials of Recombinant Vaccine Virus, MVA Strain, Expressing Genes of Human Immunodeficiency Virus;Problems of Particularly Dangerous Infections;2021-10-23